Taking people in United StatesNo phase

Mindfulness App Tested in Young Adults With Type 1 Diabetes

Tests a mindfulness app in young adults with type 1 diabetes or similar insulin deficiency.

Key facts

Who runs it: Yale University
Where: New Haven, United StatesSee the site
Trial code: NCT07062887
Registry title: Digital Mindfulness for Young Adults With Type 1 Diabetes
Status: Recruiting
People taking part: 10 people, planned
Started: 4 Feb 2026
Planned end: Sept 2026
Type of study: Interventional
Treatments tested: Mindfulness app
Record updated: 9 February 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for young adults aged 18-30 with type 1 diabetes or another diabetes with absolute insulin deficiency, to test a mindfulness app called Calm Health.

Age: 18 to 30 years
Sex: All sexes can join.
Disease stage: Type 1 diabetes or other absolute insulin deficiency diabetes (latent autoimmune diabetes of adulthood, diabetes secondary to pancreatitis), diagnosed at least 1 year ago.
Earlier treatment: Must have used a continuous glucose monitor (CGM) in routine care for at least the past 2 weeks. Must not have started new or unstable psychiatric medicine in the past 2 months.

Main reasons for not taking part

Current meditation or mindfulness practice that meets or exceeds the study's schedule
Current severe untreated psychiatric illness or active suicidal ideation
New or unstable psychiatric medicine in the past 2 months
Current or planned pregnancy during the study

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

Receiving diabetes care at Yale New Haven Children's Hospital or Yale New Haven Hospital
Sign and date informed consent form we will provide
Willingness to complete procedures and availability for duration of the study
Aged 18-30 years
Diagnosed with type 1 diabetes (T1D) or other absolute insulin deficiency diabetes (latent autoimmune diabetes of adulthood, diabetes secondary to pancreatitis) for at least 1 year
User of a continuous glucose monitor (CGM) in your routine clinical care for at least the past 2 weeks
Able to use a smartphone
Able to read and write English

Who cannot take part

Current severe untreated psychiatric illness (e.g., bipolar disorder, schizophrenia, major depression, panic disorder, borderline personality disorder, organic mood or mental disorders) or active suicidal ideation
Current meditation or mindfulness practice meeting or exceeding the study's recommended schedule
New or unstable psychopharmaceutical treatment in past 2 months
Current or planned pregnancy during study period

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

Are you between 18 and 30 years old?

Where in United States

Yale University School Of MedicineNew Haven, United StatesContact: Laura M Nally, MDTaking people

About the trial

What the trial wants to find out

The purpose of this research study is to test a mindfulness app called Calm Health among young adults with type 1 diabetes or other absolute insulin deficiency diabetes. Mindfulness is the practice of being aware of your thoughts and feelings in the moment without judgment or negative reaction. All participants will receive mindfulness guidance and personalized feedback about the relationship among your mindfulness, blood sugar, stress, and sleep.

The group in the trial

Mindfulness AppTreatment being tested
Use the mindfulness app for 6 weeks, wear an actigraphy watch, share the data from your own continuous glucose monitor (CGM), answer surveys and interviews about the app.